• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型甾体纯抗雌激素药物。

Novel steroidal pure antiestrogens.

作者信息

Bowler J, Lilley T J, Pittam J D, Wakeling A E

机构信息

Research Department 1, ICI Pharmaceuticals, Macclesfield, Cheshire, UK.

出版信息

Steroids. 1989 Jul;54(1):71-99. doi: 10.1016/0039-128x(89)90076-7.

DOI:10.1016/0039-128x(89)90076-7
PMID:2815158
Abstract

A series of steroidal estrogen antagonists with no intrinsic estrogenicity in rat uterotrophic-antiuterotrophic tests has been discovered. The compounds are derivatives of estradiol containing amidoalkyl side chains at the 7 alpha-position. The most potent compounds are N-n-butyl-N-methyl-11-(3,17 beta-dihydroxyestra- 1,3,5(10)-trien-7 alpha-yl) undecanamide and N-2,2,3,3,4,4,4-heptafluorobutyl-N-methyl-11-(3,17 beta-dihydroxyestra- 1,3,5(10)-trien-7 alpha-yl) undecanamide. Structure activity relationships are discussed.

摘要

已发现一系列在大鼠子宫营养-抗子宫营养试验中无内在雌激素活性的甾体雌激素拮抗剂。这些化合物是雌二醇的衍生物,在7α位含有酰胺烷基侧链。最有效的化合物是N-正丁基-N-甲基-11-(3,17β-二羟基雌甾-1,3,5(10)-三烯-7α-基)十一酰胺和N-2,2,3,3,4,4,4-七氟丁基-N-甲基-11-(3,17β-二羟基雌甾-1,3,5(10)-三烯-7α-基)十一酰胺。讨论了构效关系。

相似文献

1
Novel steroidal pure antiestrogens.新型甾体纯抗雌激素药物。
Steroids. 1989 Jul;54(1):71-99. doi: 10.1016/0039-128x(89)90076-7.
2
11 beta-amidoalkyl estradiols, a new series of pure antiestrogens.
J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):609-14. doi: 10.1016/0960-0760(92)90392-v.
3
1H and 13C nuclear magnetic resonance assignments and stereochemistry of N-n-butyl-N-methyl-11-(16'alpha-chloro-3',17'beta- and 17'alpha-dihydroxyestra-1',3',5'(10')-trien-7'alpha-yl) undecanamide.
Steroids. 1994 Aug;59(8):493-7. doi: 10.1016/0039-128x(94)90064-7.
4
Synthesis and biological activity of 17 alpha-alkynylamide derivatives of estradiol.
J Steroid Biochem Mol Biol. 1991 Jun;38(6):759-74. doi: 10.1016/0960-0760(91)90090-r.
5
Synthesis and biological activity of new halo-steroidal antiestrogens.新型卤代甾体抗雌激素的合成与生物活性
J Med Chem. 1991 May;34(5):1624-30. doi: 10.1021/jm00109a014.
6
Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2-dialkylated 1,2-bis(4- or 3-hydroxyphenyl)ethane estrogens and antiestrogens.烷基链分支对1,2 - 二烷基化的1,2 - 双(4 - 或3 - 羟基苯基)乙烷雌激素和抗雌激素与雌二醇受体结合亲和力及内在活性的影响。
J Med Chem. 1986 Sep;29(9):1668-74. doi: 10.1021/jm00159a018.
7
Steroidal pure antioestrogens.甾体类纯抗雌激素药物。
J Endocrinol. 1987 Mar;112(3):R7-10. doi: 10.1677/joe.0.112r007.
8
Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity.抗雌激素。2. 一系列3-芳酰基-2-芳基苯并[b]噻吩衍生物的构效关系研究,最终得到盐酸盐[6-羟基-2-(4-羟基苯基)苯并[b]噻吩-3-基][4-[2-(1-哌啶基)乙氧基]苯基]甲酮(LY156758),一种极具效力且内在雌激素活性极低的雌激素拮抗剂。
J Med Chem. 1984 Aug;27(8):1057-66. doi: 10.1021/jm00374a021.
9
Biology and mode of action of pure antioestrogens.
J Steroid Biochem. 1988;30(1-6):141-7. doi: 10.1016/0022-4731(88)90086-6.
10
Synthesis and biologic activities of 11 beta-substituted estradiol as potential antiestrogens.11β-取代雌二醇作为潜在抗雌激素的合成及生物学活性
Steroids. 1990 May;55(5):238-41. doi: 10.1016/0039-128x(90)90022-4.

引用本文的文献

1
An Estrogen Receptor β Agonist with AR Antagonist Activity from a Modern Asymmetric Steroid Synthesis.一种源自现代不对称甾体合成的具有雄激素受体拮抗活性的雌激素受体β激动剂。
ACS Med Chem Lett. 2025 Mar 27;16(4):631-637. doi: 10.1021/acsmedchemlett.5c00021. eCollection 2025 Apr 10.
2
Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status.口服选择性雌激素受体降解剂(SERDs)在乳腺癌中的应用:进展、挑战和现状。
Drug Des Devel Ther. 2022 Sep 2;16:2933-2948. doi: 10.2147/DDDT.S380925. eCollection 2022.
3
Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer.
用于治疗乳腺癌的选择性雌激素受体下调剂(SERDs)的最新进展。
RSC Med Chem. 2020 Mar 6;11(4):438-454. doi: 10.1039/c9md00570f. eCollection 2020 Apr 1.
4
Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain.组成型激活的雌激素受体拮抗剂:抗雌激素核心和侧链作用的深入了解。
ACS Chem Biol. 2018 Dec 21;13(12):3374-3384. doi: 10.1021/acschembio.8b00877. Epub 2018 Nov 26.
5
Synthesis and Biological Evaluations of Ring Substituted Tetrahydroisoquinolines (THIQs) as Anti-Breast Cancer Agents.环取代四氢异喹啉类化合物(THIQs)作为抗乳腺癌药物的合成及生物学评价
J Cancer Sci Ther. 2017;9(7):528-540. doi: 10.4172/1948-5956.1000470. Epub 2017 Jul 13.
6
Convergent synthesis of a deuterium-labeled serine dipeptide lipid for analysis of biological samples.用于生物样品分析的氘标记丝氨酸二肽脂质的汇聚合成。
J Labelled Comp Radiopharm. 2017 May 30;60(6):274-285. doi: 10.1002/jlcr.3498. Epub 2017 Apr 16.
7
Antiestrogens: structure-activity relationships and use in breast cancer treatment.抗雌激素药物:构效关系及其在乳腺癌治疗中的应用
J Mol Endocrinol. 2017 Jan;58(1):R15-R31. doi: 10.1530/JME-16-0024. Epub 2016 Oct 11.
8
Synthesis and Pharmacological Evolution of Tetrahydroisoquinolines as Anti Breast Cancer Agents.作为抗乳腺癌药物的四氢异喹啉的合成与药理演变
J Cancer Sci Ther. 2014 Apr 25;6:161-169. doi: 10.4172/1948-5956.1000266.
9
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.雌激素受体信号在乳腺癌发生及乳腺癌治疗中的调控
Cell Mol Life Sci. 2014 Apr;71(8):1549. doi: 10.1007/s00018-013-1376-3.
10
Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity.使用金属催化偶联反应合成新型雌激素受体拮抗剂及其生物学活性的表征。
J Med Chem. 2013 Apr 11;56(7):2779-90. doi: 10.1021/jm3013773. Epub 2013 Mar 26.